Trial Profile
Phase I Study Of Cloretazine (VNP40101M) In Children With Recurrent, Progressive Or Refractory Primary Brain Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Jul 2011
Price :
$35
*
At a glance
- Drugs Laromustine (Primary)
- Indications Brain cancer; Glioma
- Focus Adverse reactions
- 22 Feb 2008 Status change from in progress to completed.
- 01 Nov 2006 Status change
- 19 Aug 2005 New trial record.